Mark Harrison, PhD
Faculty of Pharmaceutical Sciences, University of British Columbia
University of British Columbia
Vancouver,
BC
Canada
Papers:
DOES INTRODUCING IMPRECISION AROUND PROBABILITIES FOR BENEFIT AND HARM INFLUENCE THE WAY PEOPLE VALUE TREATMENTS?
Student?
yes
SMDM Member?
yes